Ketovision (Ketorolac Trometamol)

Ketorolac trometamol blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes in ocular tissues. By inhibiting these enzymes, it lowers prostaglandin production, which diminishes the inflammatory response and associated pain within the eye.

The dosing regimen for Ketovision is determined by the prescribing ophthalmologist based on the specific surgical procedure and patient response. The prescriber will indicate the number of drops, frequency, and duration of therapy.

Safety data for ketorolac trometamol in pregnancy and lactation are limited. It is generally advised to avoid use during pregnancy unless the potential benefit outweighs the risk, and to exercise caution when breastfeeding, consulting a healthcare professional.

To request Ketovision, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketovision contains ketorolac, a potent NSAID with a rapid onset of action. Compared with other ophthalmic NSAIDs such as diclofenac or bromfenac, ketorolac often provides stronger analgesia and anti‑inflammatory effects, though individual response and tolerability may vary.

Ketovision should be stored at room temperature, below 25 °C, in its original packaging. Protect the bottle from excessive light and moisture to maintain stability and potency.

Ketovision is applied as eye drops. The patient tilts the head back, pulls down the lower eyelid, and instills the prescribed number of drops into the conjunctival sac, typically avoiding contact between the tip and the eye or any surface.

Serious risks, although rare, include corneal ulceration, severe allergic reactions such as anaphylaxis, and a possible increase in intraocular pressure. Patients should be monitored for any worsening of vision or ocular discomfort and seek immediate medical attention if these occur.

Ketovision should not be used by individuals with a known hypersensitivity to ketorolac, other NSAIDs, or any component of the formulation. Caution is also advised for patients with active corneal disease, uncontrolled glaucoma, or those who are pregnant unless clearly indicated.